Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï 500¿¹ÀÇ ÀÓ»óÀû °íÂû A Clinical Study of 500 Cases of Breast Cancer

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 6È£ p.1061 ~ 1068
¹ÚÀνÄ, À̸̹®³ª, ±¸ÀÚÀ±, ÃÖ½ÂÈÆ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÀνĠ(  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

À̸̹®³ª (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±¸ÀÚÀ± (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÃÖ½ÂÈÆ (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract

°á·Ð
À¯¹æ¾ÏÀÇ È£¹ß¿¬·É±ºÀº 40´ë·Î ¼­±¸¿¡ ºñÇÏ¿© ÀþÀº ¿¬·ÉÃþÀÇ ºñÁßÀÌ ³ô¾Ò´Ù. ÁÖÁõ»óÀº Á¾
±«ÀÇ ÃËÁö°¡ °¡Àå ¸¹¾ÒÀ¸¸ç Á¤±â°ËÁøÁß À¯¹æÃÔ¿µÀÌ»óÀ¸·Î ¹ß°ßµÈ °æ¿ì°¡ 8.4%¿´´Ù. Stage
¥°, ¥±ÀÇ À¯¹æ¾Ï¿¡¼­ À¯¹æº¸Á¸¼úÀÌ Á¡Â÷ Áõ°¡µÇ¾î 33.6%·Î ³ôÀº ½ÃÇà·üÀ» º¸¿´°í º¯Çü ±ÙÄ¡
Àû À¯¹æ ÀýÁ¦¼úÀÌ 52.8%¿´´Âµ¥ ¾ç±º°£ÀÇ ½ÇÁ¦ »ýÁ¸À², ¹«º´ »ýÁ¸À²¿¡´Â Åë°èÀûÀ¸·Î À¯ÀÇÇÑ
Â÷ÀÌ°¡ ¾ø¾ú´Ù. °á·ÐÀûÀ¸·Î 40´ëÀÇ È£¹ß¿¬·É±º¿¡¼­ Á¤±âÀûÀÎ °ËÁøÀÌÀ¯ ¹æ¾ÏÀÇ Á¶±â ¹ß°ß¿¡
µµ¿òÀÌ µÉ °ÍÀ¸·Î »ý°¢µÇ°í ¶ÇÇÑ Ãʱâ À¯¹æ¾Ï¿¡¼­ À¯¹æ º¸Á¸¼úÀÌ Á¡Â÷ Áõ°¡ ÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.
#ÃÊ·Ï#
Purpose : We investigated the clinical characteristics of breast cancers and its
significance.
Material and method : We evaluated the clinical characteristics of 500 women with
breast cancer who were diagnosed and treated by one surgeon between March 1991 and
August 1996.
Results : The median age was 46.7 years and the most common age group was 40's.
The presenting symptoms for most patients were palpable mass(75.2%) followed by
abnormal mammographic findings(8.4%), pain(6.3%) and nipple discharges(4.7%), and the
duration of symptoms was less than 1 month in 41.4%. Fifty three percent of the 500
cases had T2 lesion(size; 2 to 5 cm). With the increase of tumor size,
overall and disease free survival rates(OS, DFS) were decreased. Surgical treatment
consisted of modified radical mastectomy(52.8%) and partial mastectomy(33.6%) The
most common stage was ¥±(42.3%) and the early breast cancer(stage 0, ¥°, ¥±) was
388cases(78.1%) and the stage were inversely correlated with DFS and OS. The
positivity of axillary lymph node was 39.3% and the number of the metastatic lymph
nodes was inversely correlated with DFS and OS. The pathologic types were infiltrating
ductal carcinoma(83.0%), ductal carcinoma in situ(12.8%), infiltrating lobular
carcinoma(1.2%), lobular carcinoma in situ(0.4%) and Paget's disease(2.0%). ER
positivity was 48.9% and PR 46.9%. ER positive patients showed survival benefit
compared to ER negative patients. The common sites of distant metastases were lung,
bone and liver.
Conclusions : Our patients with breast cancer were younger than those of western
and showed the impacts on survival according to the lymph node status, tumor size.

Å°¿öµå

Breast cancer; Clinical characteristics; Survival rates;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS